Pharmaceutical research centre
L.S. Skaggs Pharmacy Institute is a new research facility opened in April 2013 for the College of Pharmacy at the University of Utah (U of U) in Salt Lake City in the state of Utah itself, US.
The institute is dedicated to interdisciplinary research and development of new drugs for the treatment of diseases such as osteoarthritis, cancer and epilepsy, as well as wound healing. It is part of the Health Sciences Center of the University of Utah.
The pharmaceutical research complex is named in the honour of Leonard Samuel Skaggs, who along with his family’s ALSAM Foundation, contributed about $50m towards the new research centre, in 2007.
Construction of the facility was started in August 2009 and concluded in April 2013. The project cost more than $75m.
The Utah College of Pharmacy has been ranked among the top four institutes in the US by the National Institutes of Health (NIH). It is also the second best in pharmaceutical research productivity (only behind the University of California) and received $23m from the NIH in 2011.
The institute has so far screened 30,000 epilepsy compounds leading to the development of 11 new medications for the disease through the Anticonvulsant Drug Development Program. The college also provides research on new medication and drug delivery systems.
The new facility has been a long delayed plan of the University of Utah to provide additional state-of-the-art wet and dry research laboratories for the College of Pharmacy.
The new building provides improved lighting, electrical and cooling systems to facilitate installation of larger equipment and enable rigorous research experiments to take place.
The project included construction of a new 30,000ft², five-storey Pharmacy Research Building on the site of a former car parking lot. It is situated adjacent to the existing Skaggs Hall, the Pharmacy College facility built in 1965. The building was built with contributions from L.S. Skaggs, Sr.
The new pharmaceuticals research facility added two levels of unfinished open laboratory space, open research laboratories on another two floors, offices and conference rooms, a vivarium, a translational centre, computer imaging laboratories, one level of underground parking, utilities and support spaces. It also accommodates the Utah Poison Control Center.
A new glass atrium connects the new facility with L. S. Skaggs Sr Hall and provides spaces for faculty and students to gather in the cafe or in small lounge areas. The four floors of atrium space have elevators and meeting and studying areas. The fourth floor houses a state-of-the-art call centre and office suite for the Utah Poison Control Center.
The atrium also features an amphitheatre for presentations and other events at its west entrance. It is anticipated to promote scientific and medical interactions. It will also provide structural stability for the existing hall. The entire complex is renamed as the L.S. Skaggs Pharmacy Institute.
The 150,000ft2 research and educational complex brings together six different department facilities of the college lying across the campus under one roof. The facilities to be integrated include the department of Pharmaceutics and Pharmaceutical Chemistry, Pharmacotherapy, Pharmacology and Toxicology and Medicinal Chemistry.
The new laboratory facility is expected to consume nearly 30% less energy than similar university facilities. It is also expected to save about 79% of the domestic water through reuse techniques.
The building also features energy saving façades, shading systems, sensors, roof insulations and HVAC systems. It is anticipated that it will achieve LEED Gold certification.
University of Utah’s new innovation centre, the James L. Sorenson Molecular Biotechnology Building, was officially dedicated in 2012.
NBBJ Architects and EDA Architects were selected in 2009 to design the facility.
The NBBJ/EDA joint venture was also the master plan designer of the pharmacy campus.
Construction of the building was carried out by Jacobsen Construction under a $54m contract with the State of Utah.
Van Boerum & Frank Associates (VBFA) was the mechanical engineer and Envision Engineering was the electrical engineer.
Psomas was the civil engineering consultant. ArcSitio was the landscaping engineer. Atelier Ten was the environmental design and building services consultant.
Other consultant engineers included Gale Bate, Colin Gordon, Dunn & Associates, Spectrum and CCP.
Thermo Fisher Scientific (Thermo Fisher) will establish a new pharmaceutical services facility for integrated biologics and sterile drug development and…
Arranta Bio is constructing a new multi-product, commercial-ready manufacturing facility in Watertown, Massachusetts, US. Watertown facility will be used for…
Berkshire Sterile Manufacturing (BSM) is expanding its manufacturing facility in Lee, Massachusetts (MA), US. The company began preparations for the…
Lykan Bioscience opened a purpose-built SMART Manufacturing™ facility for developing cell-based therapies in Hopkinton, Massachusetts, US, in September 2020. The…